Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A modular, fully integrated ultra-high-throughput screening system based on confocal fluorescence analysis

Stefan Jäger1, Norbert Garbow, Achim Kirsch

  • 1Evotec OAI/Evotec Technologies, Hamburg, Germany. stefan.jaeger@evotecoai.com

Journal of Biomolecular Screening
|January 9, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>.

Journal of medicinal chemistry·2026
Same author

Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 Inhibitors.

Journal of medicinal chemistry·2026
Same author

Single-cell mitochondrial morphomics reveals cellular heterogeneity and predicts complex I, III, and ATP synthase Inhibition responses.

Scientific reports·2025
Same author

Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.

ACS medicinal chemistry letters·2024
Same author

High-Throughput Determination of Infectious Virus Titers by Kinetic Measurement of Infection-Induced Changes in Cell Morphology.

International journal of molecular sciences·2024
Same author

Identification of novel bromodomain inhibitors of <i>Trypanosoma cruzi</i> bromodomain factor 2 (<i>Tc</i>BDF2) using a fluorescence polarization-based high-throughput assay.

Antimicrobial agents and chemotherapy·2024

A new miniaturized ultra-high-throughput screening (uHTS) system was developed for drug discovery. This system uses novel confocal fluorescence readers to achieve high data quality in small assay volumes, enabling efficient screening of compound libraries.

Area of Science:

  • Biotechnology
  • Pharmaceutical Science
  • Analytical Chemistry

Background:

  • The increasing size of compound libraries and new drug targets necessitate advancements in screening technologies.
  • Existing ultra-high-throughput screening (uHTS) systems require improvements in data quality and operational reliability for miniaturized assays.

Purpose of the Study:

  • To develop a modular, fully integrated system for miniaturized uHTS.
  • To achieve high data quality in small assay volumes (1-4 microL) with reliable, unattended operation.
  • To design and validate novel confocal fluorescence readers for diverse assay types.

Main Methods:

  • Development of a modular, integrated uHTS system.
  • Design of two confocal fluorescence readers: a 4-channel parallel reader and an imaging reader.

Related Experiment Videos

  • Utilizing single-molecule detection methods for high sensitivity fluorescence readout.
  • Analysis of imaging data using generic patterns and intensity per pixel quantification.
  • Main Results:

    • The developed uHTS system successfully operates in small assay volumes (1-4 microL).
    • The 4-channel reader is suitable for isolated targets and membrane vesicle assays.
    • The imaging reader is effective for cell-based assays.
    • Comprehensive testing demonstrated high data quality and system robustness across various assay types.

    Conclusions:

    • The new miniaturized uHTS system meets the demands of modern drug discovery.
    • The developed confocal fluorescence readers offer versatile and sensitive solutions for uHTS.
    • The system provides a robust platform for efficient and reliable screening of large compound libraries.